Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma

Adam C. Berger(Fox Chase Cancer Center), John P. Hoffman(Fox Chase Cancer Center), James C. Watson(Vanderbilt University), Ingrid M. Meszoely(Fox Chase Cancer Center), Eric A. Ross(Fox Chase Cancer Center)
Annals of Surgical Oncology
June 15, 2004
Cited by 131


Related Papers